A specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic drugs across areas such as dermatology, gastroenterology, and eye health through its Bausch + Lomb division. The business historically relied on acquisitions to expand its portfolio and global ...
6 members of Congress have disclosed 23 trades in Valeant Pharmaceuticals International, Inc. (VRX), a Healthcare company. The buy/sell breakdown shows 13 purchases versus 10 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-02-19 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-10-08 | David E. Price | sell | $1K – $15K |
| 2015-01-26 | David E. Price | sell | $1K – $15K |
| 2014-05-07 | Susan M Collins | sell | $1K – $15K |
| 2014-03-11 | Susan M Collins | buy | $1K – $15K |
| 2012-03-10 | Lamar Smith | buy | $1K – $15K |
| 2011-12-07 | SHELLEY BERKLEY | sell | — |
| 2011-12-07 | SHELLEY BERKLEY | sell | — |
| 2011-12-07 | SHELLEY BERKLEY | sell | $2,350.75 |
| 2011-08-03 | SHELLEY BERKLEY | sell | $588.39 |
| 2011-06-05 | MICHAEL T. MCCAUL | buy | $15K – $50K |
| 2011-05-05 | SHELLEY BERKLEY | buy | — |
| 2011-04-08 | SHELLEY BERKLEY | buy | $49,900 |
| 2010-12-05 | SHELLEY BERKLEY | sell | 394.23 |
| 2010-08-03 | SHELLEY BERKLEY | buy | -$615.65 |
| 2010-04-07 | MICHAEL N. CASTLE | sell | less than $1,000 |
| 2010-04-06 | SHELLEY BERKLEY | buy | $561.35 |
| 2010-01-12 | SHELLEY BERKLEY | buy | -$1,149.60 |
| 2010-01-10 | SHELLEY BERKLEY | buy | -716.28 |
| 2010-01-09 | SHELLEY BERKLEY | buy | $-421.02 |
| 2009-08-10 | SHELLEY BERKLEY | buy | -1,453.24 |
| 2009-08-10 | SHELLEY BERKLEY | buy | -1,453.24 |
| 2008-09-09 | SHELLEY BERKLEY | sell | — |